3 Followers on Owler
OverviewCompetitorsNews & Insights

Allenex AB Competitors or Alternatives

Allenex AB's top competitors include BioInvent, NeuroVive and Active Biotech.

Unlock 15 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Allenex AB's company profile

Anders Karlsson

CEO

69/100
57
$0
$14.5M
  • $0
    $14.5M
  • 57
    $0
  • $14.5M
  • 69/100
  • 57
  • $0
  • $14.5M
View ProfileView
1
Allenex AB's Competitor - BioInvent logo

Martin Welschof

President & CEO

92/100
93
$34.5M
$30.4M
  • $34.5M
    $30.4M
  • 93
    $34.5M
  • $30.4M
  • 92/100
  • 93
  • $34.5M
  • $30.4M
View ProfileView
2
Allenex AB's Competitor - NeuroVive logo

Erik Kinnman

CEO

88/100
9
$3.2M
$ < 1M
  • $3.2M
    $ < 1M
  • 9
    $3.2M
  • $ < 1M
  • 88/100
  • 9
  • $3.2M
  • $ < 1M
View ProfileView
3
Allenex AB's Competitor - Active Biotech logo

Tomas Leanderson

President & CEO

69/100
17
- -
$ < 1M
  • - -
    $ < 1M
  • 17
    - -
  • $ < 1M
  • 69/100
  • 17
  • - -
  • $ < 1M
View ProfileView
4
Allenex AB's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

51/100
25,200
$4.1B
$33.4B
  • $4.1B
    $33.4B
  • 25,200
    $4.1B
  • $33.4B
  • 51/100
  • 25,200
  • $4.1B
  • $33.4B
View ProfileView
5
Allenex AB's Competitor - Mitobridge logo

Mike Patane

President

90/100
25 - 100
$5.2M
$100K - 5M
  • $5.2M
    $100K - 5M
  • 25 - 100
    $5.2M
  • $100K - 5M
  • 90/100
  • 25 - 100
  • $5.2M
  • $100K - 5M
View ProfileView
Allenex AB's top 18 competitors are BioInvent, NeuroVive, Active Biotech, Orexo, Amgen, Mitobridge, Stealth, GENFIT, Pfizer, Phenex, MSDC, Novartis, Mission Therapeutics, AstraZeneca, Karo Bio, Lilly, Merck and Beactica. Together they have raised over 14.2B between their estimated 382.7K employees. Allenex AB has 57 employees and is ranked lowest among it's top 10 competitors. The top 10 competitors average 20,143.

Allenex AB VS BioInvent

BioInvent is a top competitor of Allenex AB. BioInvent is a Public company that was founded in 1996 in Lund, Skåne län. BioInvent operates in the Biotechnology industry. Compared to Allenex AB, BioInvent has 36 more employees.

Allenex AB VS NeuroVive

NeuroVive is seen as one of Allenex AB's biggest rivals. NeuroVive was founded in 1998, and is headquartered in Lund, Skåne län. NeuroVive is in the Pharmaceuticals industry. NeuroVive generates $14.5M less revenue vs. Allenex AB.

Allenex AB VS Active Biotech

Active Biotech is seen as one of Allenex AB's top competitors. Active Biotech was founded in Lund, Skåne län} in 1996. Active Biotech competes in the Biotechnology industry. Compared to Allenex AB, Active Biotech generates $13.7M less revenue.

Looking for similar companies to Allenex AB?

Similar Companies

Biotechnology companies in Stockholm

See 24 companies 
Pharmaceuticals & Biotechnology companies in Stockholm

See 50 companies 
Biotechnology companies in Stockholms län

See 45 companies 
Pharmaceuticals & Biotechnology companies in Stockholms län

See 88 companies 
Biotechnology companies in Sweden

See 267 companies 
Pharmaceuticals & Biotechnology companies in Sweden

See 477 companies 
Companies in Stockholm with revenue in $5.0-25M range

See 686 companies 
Companies in Stockholms län with revenue in $5.0-25M range

See 836 companies 
Companies in Stockholm with employees in 25-100 range

See 874 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Allenex AB and Allenex AB's Competitors

April 29, 2025FinanzNachrichten
LUND, SE / ACCESS Newswire / April 29, 2025 / BioInvent International (STO:BINV)"The first quarter of 2025 was a highly productive period across clinic...
April 29, 2025Benzinga
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutica...
April 30, 2025Medthority
The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and statistically sig...
April 30, 2025Endpoints News
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
April 29, 2025Marketscreener
CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
April 29, 2025Zacks
Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for ma...
April 30, 2025Nasdaq
Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance follo...
April 29, 2025StreetInsider
- FDA decision on elamipretide for the treatment of Barth syndrome delayed -- Labelling discussions underway, but no revised action date communicated b...
April 29, 2025NewYork Post
The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the compan...
April 30, 2025Nasdaq
Bristol Myers Squibb (NYSE:BMY) recently reported its first-quarter results, with adjusted earnings of $1.80 per share on revenue of $11.2 billion. Thi...

Frequently Asked Questions about Allenex AB

  1. Who are Allenex AB's top competitors?

    Allenex AB's top 3 competitors are BioInvent, NeuroVive, Active Biotech.

  2. Who is similar to Allenex AB?

    BioInvent is the most similar to Allenex AB. NeuroVive and Active Biotech are also similar to Allenex AB.

  1. Are Allenex AB and BioInvent competitors?

    Yes, BioInvent is one of Allenex AB’s top competitors.